Endocrine Disorders in Children with Primary Mitochondrial Diseases: Single Center Experience
PDF

Original Article

Endocrine Disorders in Children with Primary Mitochondrial Diseases: Single Center Experience

J Clin Res Pediatr Endocrinol 2025;17(1):34-45 DOI: 10.4274/jcrpe.galenos.2024.2024-1-11
, , ,
PDF
Permissions

Abstract

Objective

Endocrine abnormalities may be the only clinical manifestation of primary mitochondrial disorders. The aim of this study was to evaluate the endocrinological characteristics of mitochondrial disease (MD) in a cohort from a single center.

Methods

Pediatric patients diagnosed with MD were categorized on the basis of their specific genetic abnormalities. The auxologic data, pubertal development, and, based on their clinical symptoms, hormonal profiles were obtained.

Results

Twelve of the cohort of 26 patients (46%) were female. In 15 (57.6%), the MD was caused by nuclear DNA mutations (nDNA group). Four patients had Leigh syndrome, two patients had Leber’s Hereditary Optic Neuropathy syndrome, two patients had Mitochondrial Encephalopathy Lactic Acidosis and Stroke Like episodes, and one patient had Kearns-Sayre syndrome clinical phenotype. The median age at diagnosis was 2.91 (0.59-16.8) years, and the median age at first endocrine evaluation was 4.62 (1.26-18) years. The mean height standard deviation score (SDS) was -1.34±2.12, and the mean body mass index SDS was -0.82±1.96 for all patients. Of the 26 patients, 6 (23%) had a range of hormonal deficits. Ovarian insufficiency, central adrenal insufficiency, central hypothyroidism, diabetes mellitus, and critical illness-related adrenal insufficiency were all observed. Three of the patients were initially monitored in the endocrine clinic for hormone deficiencies but it was later determined that the hormonal abnormalities were caused by underlying MD.

Conclusion

Individuals diagnosed with MD, particularly those with specific genetic abnormalities, are considered a high-risk group for developing hormonal deficits. Endocrine abnormalities may be one of the primary early warning symptoms for MD.

Keywords: Primary mitochondrial disease, genotype-phenotype, endocrine disorders, endocrin abnormalities

Read the full text

5 sections · 4 tables · PDF

Create your free account to read the full text.

  • Full text with figures and tables
  • PDF and supplementary files
  • Access on every Galenos journal
Get free access

Already have an account?

Sign in
or
Continue with Google

One Galenos account works on every Galenos journal site.

References

1

Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R, Yu-Wai-Man P, Chinnery PF, Taylor RW, Turnbull DM, McFarland R. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease. Ann Neurol 2015;77:753-759.

2

Kohda M, Tokuzawa Y, Kishita Y, Nyuzuki H, Moriyama Y, Mizuno Y, Hirata T, Yatsuka Y, Yamashita-Sugahara Y, Nakachi Y, Kato H, Okuda A, Tamaru S, Borna NN, Banshoya K, Aigaki T, Sato-Miyata Y, Ohnuma K, Suzuki T, Nagao A, Maehata H, Matsuda F, Higasa K, Nagasaki M, Yasuda J, Yamamoto M, Fushimi T, Shimura M, Kaiho-Ichimoto K, Harashima H, Yamazaki T, Mori M, Murayama K, Ohtake A, Okazaki Y. A comprehensive genomic analysis reveals the genetic landscape of mitochondrial respiratory chain complex deficiencies. PLoS Genet. 2016;12:e1005679.

3

Payne BA, Wilson IJ, Yu-Wai-Man P, Coxhead J, Deehan D, Horvath R, Taylor RW, Samuels DC, Santibanez-Koref M, Chinnery PF. Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet. 2013;22:384-390. Epub 2012 Oct 16

4

Wang Z, Ying Z, Bosy-Westphal A, Zhang J, Schautz B, Later W, Heymsfield SB, Müller MJ. Specific metabolic rates of major organs and tissues across adulthood: evaluation by mechanistic model of resting energy expenditure. Am J Clin Nutr. 2010;92:1369-1377. Epub 2010 Oct 20

5

Parikh S, Saneto R, Falk MJ, Anselm I, Cohen BH, Haas R, the Mitochondrial Medicine Society. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol. 2009;11:414-430.

6

Rahman S. Mitochondrial disease in children. J Intern Med. 2020;287:609-633. Epub 2020 Apr 7

7

Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Prevalence and progression of diabetes in mitochondrial disease. Diabetologia. 2007;50:2085-2089. Epub 2007 Jul 26

8

Ng YS, Lim AZ, Panagiotou G, Turnbull DM, Walker M. Endocrine manifestations and new developments in mitochondrial disease. Endocr Rev. 2022;43:583-609.

9

Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE. Endocrine disorders in primary mitochondrial disease. J Endocr Soc. 2018;2:361-373.

10

Neyzi O, Bundak R, Gökçay G, Günöz H, Furman A, Darendeliler F, Baş F. Reference values for weight, height, head circumference, and body mass i3ndex in Turkish children. J Clin Res Pediatr Endocrinol. 2015;7:280-293.

11

Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu MM, Akın MA, Çoban D, Gökoğlu S, Baştuğ O. Body weight, length and head circumference at birth in a cohort of Turkish newborns. J Clin Res Pediatr Endocrinol. 2012;4:132-139. Epub 2012 May 4

12

Stoffers AJ, Weber DR, Levine MA. An update on vitamin D deficiency in the twenty-first century: nature and nurture. Curr Opin Endocrinol Diabetes Obes. 2022;29:36-43.

13

Rakıcıoğlu N, Acar Tek N, Ayaz A, Pekcan G. Food and Nutrition Photo Catalog, Measurements and Quantities. 5th ed. Ankara, Hacettepe University Publications, 2017.

14

Ebispro for Windows, Stuttgart, Germany; Turkish Version (BeBiS 8.2), Pasifik Elektrik Elektronik Ltd. Şti.; İstanbul, 2019. Available from: www.bebis.com.tr

15

TürKomp, Ulusal Gıda Kompozisyon Veri Tabanı, versiyon 1.0. Energy and macronutrient intakes were compared with recommended daily allowances (RDA) and dietary reference intake (DRI) values. Available from: www.turkomp.gov.tr

16

Subcommittee on the Tenth Edition of the RDAs Food and Nutrition Board Commission on Life Sciences National Research Council. Recommended Dietary Allowances (RDA). 10th ed. Washington (DC): National Academy Press, 1989.

17

Institute of Medicine Food and Nutrition Board. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Institute of Medicine. Washington DC, National Academies Press, 2005.

18

Lobelo F, Muth ND, Hanson S, Nemeth BA; Council on Sports Medicine and Fitness; Section on Obesity. Physical Activity Assessment and Counseling in Pediatric Clinical Settings. Pediatrics. 2020;145:e20193992.

19

FAO/WHO/UNU Expert Consultation. Human energy requirements. Rome: World Health Organization, 2004. Available from: https://www.fao.org/3/y5686e/y5686e00.htm#Contents

20

Gedikbasi A, Toksoy G, Karaca M, Gulec C, Balci MC, Gunes D, Gunes S, Aslanger AD, Unverengil G, Karaman B, Basaran S, Demirkol M, Gokcay GF, Uyguner ZO. Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases. Front Genet. 2023;14:1191159.

21

Parikh S, Goldstein A, Karaa A, Koenig MK, Anselm I, Brunel-Guitton C, Christodoulou J, Cohen BH, Dimmock D, Enns GM, Falk MJ, Feigenbaum A, Frye RE, Ganesh J, Griesemer D, Haas R, Horvath R, Korson M, Kruer MC, Mancuso M, McCormack S, Raboisson MJ, Reimschisel T, Salvarinova R, Saneto RP, Scaglia F, Shoffner J, Stacpoole PW, Sue CM, Tarnopolsky M, Van Karnebeek C, Wolfe LA, Cunningham ZZ, Rahman S, Chinnery PF. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med. 2017;19:10.1038/gim.2017.107. Epub 2017 Jul 27

22

Sue CM, Balasubramaniam S, Bratkovic D, Bonifant C, Christodoulou J, Coman D, Crawley K, Edema-Hildebrand F, Ellaway C, Ghaoui R, Kava M, Kearns LS, Lee J, Liang C, Mackey DA, Murray S, Needham M, Rius R, Russell J, Smith NJC, Thyagarajan D, Wools C. Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations. Intern Med J. 2022;52:110-120. Epub 2021 Nov 19

23

Pickett SJ, Grady JP, Ng YS, Gorman GS, Schaefer AM, Wilson IJ, Cordell HJ, Turnbull DM, Taylor RW, McFarland R. Phenotypic heterogeneity in m.3243A>G mitochondrial disease: The role of nuclear factors. Ann Clin Transl Neurol. 2018;5:333-345.

24

Pitceathly RD, Smith C, Fratter C, Alston CL, He L, Craig K, Blakely EL, Evans JC, Taylor J, Shabbir Z, Deschauer M, Pohl U, Roberts ME, Jackson MC, Halfpenny CA, Turnpenny PD, Lunt PW, Hanna MG, Schaefer AM, McFarland R, Horvath R, Chinnery PF, Turnbull DM, Poulton J, Taylor RW, Gorman GS. Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain. 2012;135:3392-3403. Epub 2012 Oct 29

25

Von Kleist-Retzow JC, Cormier-Daire V, Viot G, Goldenberg A, Mardach B, Amiel J, Saada P, Dumez Y, Brunelle F, Saudubray JM, Chrétien D, Rötig A, Rustin P, Munnich A, De Lonlay P. Antenatal manifestations of mitochondrial respiratory chain deficiency. J Pediatr. 2003;143:208-212.

26

Finsterer J, Frank M. Growth-hormone deficiency in mitochondrial disorders. J Pediatr Endocrinol Metab. 2017;30:479-481.

27

Wolny S, McFarland R, Chinnery P, Cheetham T. Abnormal growth in mitochondrial disease. Acta Paediatr. 2009;98:553-554. Epub 2008 Dec 18

28

Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S. Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol. 2017;13:92-104. Epub 2016 Oct 7

29

Tiosano D, Mears JA, Buchner DA. Mitochondrial dysfunction in primary ovarian insufficiency. Endocrinology. 2019;160:2353-2366.

30

Demain LAM, Antunes D, O’Sullivan J, Bhaskhar SS, O’Keefe RT, Newman WG. A known pathogenic variant in the essential mitochondrial translation gene RMND1 causes a Perrault-like syndrome with renal defects. Clin Genet. 2018;94:276-277. Epub 2018 Apr 19

31

Ng YS, Alston CL, Diodato D, Morris AA, Ulrick N, Kmoch S, Houštěk J, Martinelli D, Haghighi A, Atiq M, Gamero MA, Garcia-Martinez E, Kratochvílová H, Santra S, Brown RM, Brown GK, Ragge N, Monavari A, Pysden K, Ravn K, Casey JP, Khan A, Chakrapani A, Vassallo G, Simons C, McKeever K, O’Sullivan S, Childs AM, Østergaard E, Vanderver A, Goldstein A, Vogt J, Taylor RW, McFarland R. The clinical, biochemical and genetic features associated with RMND1-related mitochondrial disease. J Med Genet. 2016;53:768-775. Epub 2016 Jul 13

32

Janer A, Antonicka H, Lalonde E, Nishimura T, Sasarman F, Brown GK, Brown RM, Majewski J, Shoubridge EA. An RMND1 Mutation causes encephalopathy associated with multiple oxidative phosphorylation complex deficiencies and a mitochondrial translation defect. Am J Hum Genet. 2012;91:737-743. Epub 2012 Sep 27

33

Garcia-Diaz B, Barros MH, Sanna-Cherchi S, Emmanuele V, Akman HO, Ferreiro-Barros CC, Horvath R, Tadesse S, El Gharaby N, DiMauro S, De Vivo DC, Shokr A, Hirano M, Quinzii CM. Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. Am J Hum Genet. 2012;91:729-736. Epub 2012 Sep 27

34

Boros E, Elilié Mawa Ongoth F, Heinrichs C, Mansbach AL, Seneca S, Aeby A, Ismaïli K, Brachet C. Primary ovarian insufficiency in RMND1 mitochondrial disease. Mitochondrion. 2022;66:51-53. Epub 2022 Jul 25

35

Sasaki H, Kuzuhara S, Kanazawa I, Nakanishi T, Ogata T. Myoclonus, cerebellar disorder, neuropathy, mitochondrial myopathy, and ACTH deficiency. Neurology. 1983;33:1288-1293.

36

Siri B, D’Alessandro A, Maiorana A, Porzio O, Ravà L, Dionisi-Vici C, Cappa M, Martinelli D. Adrenocortical function in patients with single large scale mitochondrial DNA deletions: a retrospective single centre cohort study. Eur J Endocrinol. 2023;189:485-494.

37

Téblick A, Peeters B, Langouche L, Van den Berghe G. Adrenal function and dysfunction in critically ill patients. Nat Rev Endocrinol. 2019;15:417-427.

38

Meimaridou E, Hughes CR, Kowalczyk J, Guasti L, Chapple JP, King PJ, Chan LF, Clark AJ, Metherell LA. Familial glucocorticoid deficiency: New genes and mechanisms. Mol Cell Endocrinol. 2013;371:195-200. Epub 2012 Dec 29

39

Kobayashi T, Oka Y, Katagiri H, Falorni A, Kasuga A, Takei I, Nakanishi K, Murase T, Kosaka K, Lernmark A. Association between HLA and islet cell antibodies in diabetic patients with a mitochondrial DNA mutation at base pair 3243. Diabetologia. 1996;39:1196-1200.

40

Karaa A, Goldstein A. The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes. 2015;16:1-9. Epub 2014 Oct 20

41

Berio A, Piazzi A. A case of Kearns-Sayre syndrome with autoimmune thyroiditis and complete atrio-ventricular block. Minerva Cardioangiol. 2006;54:387-391.

42

Sanaker PS, Husebye ES, Fondenes O, Bindoff LA. Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure. Acta Neurol Scand Suppl. 2007;187:64-67.